Ron Alfa, MD, Ph.D, Recursion Pharmaceuticals

Ron Alfa, MD, Ph.D

Dr. Alfa is Vice President, Discovery and Product at Recursion Pharmaceuticals (recursionpharma.com), an AI-enabled drug discovery company combining state-of-the-art machine learning with automated cell biology. At Recursion, he leads Product across the organization working closely with all teams to leverage computational tools & robotics to solve important drug discovery challenges. He received training in Neurosciences, Medicine, and Entrepreneurship at Stanford University and has made scientific contributions to the fields of Neurosciences, Metabolism, and Genetics. Prior to Recursion, Dr. Alfa worked closely with biotech start-ups at Stanford-affiliated accelerator, StartX.

Session

10:55 AM - 11:20 AM

R&D Use Cases Part I

Drug Discovery is a long process that AI technologies and tools are beginning to help shorten.  The speakers in this two-part R&D Use Case session will present information on current projects where they are applying AI.  They will cover the inputs and outcomes, as well as share insights from applying AI  to their discovery projects

  • Ron Alfa, MD, Ph.D

    Ron Alfa, MD, Ph.D Senior Vice President, Translational Discovery Recursion Pharmaceuticals


Download Latest Agenda